However, in the late stage of cancer progression, cancer cells become resistant to the cytostatic effects of TGF-β1, and TGF-β1 in turn promotes cancer metastasis by inducing epithelial-mesenchymal transition, angiogenesis, and immune evasion. Here, TGFB1 is linked to cancer.